Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.

Geiss HC, Otto C, Hund-Wissner E, Parhofer KG.

Atherosclerosis. 2005 May;180(1):107-12. Epub 2004 Dec 29.

PMID:
15823282
2.

[Ezetimibe: from pharmacology to clinical trials].

Tellier P.

Ann Endocrinol (Paris). 2003 Dec;64(6):442-7. Review. French.

PMID:
15067249
3.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
4.

Comparison of statins in hypertriglyceridemia.

Stein EA, Lane M, Laskarzewski P.

Am J Cardiol. 1998 Feb 26;81(4A):66B-69B. Review.

PMID:
9526817
5.

Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.

Robinson JG, Davidson MH.

Expert Rev Cardiovasc Ther. 2006 Jul;4(4):461-76. Review. Erratum in: Expert Rev Cardiovasc Ther. 2006 Sep;4(5):772.

PMID:
16918265
6.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
7.

Combination of a sterol absorption inhibitor and cardiovascular agents for the treatment of dyslipidemia.

Chrysohoou C, Singh S.

Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):73-8. Review.

PMID:
18221076
8.

The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes?

Rizzo M, Rini GB, Spinas GA, Berneis K.

Atherosclerosis. 2009 Jun;204(2):330-3. doi: 10.1016/j.atherosclerosis.2008.10.005. Epub 2008 Oct 14. Review.

PMID:
19027905
9.

Combination therapy.

Denke MA.

J Manag Care Pharm. 2003 Jan-Feb;9(1 Suppl):17-9. Review.

10.
11.

Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.

Page MM, Ekinci EI, Jones RM, Angus PW, Gow PJ, O'Brien RC.

Intern Med J. 2014 Jun;44(6):601-4. doi: 10.1111/imj.12444. Review. Erratum in: Intern Med J. 2014 Oct;44(10):1050.

PMID:
24946816
12.

[Hypercholesterolemia - Where are we today? Where are we going?].

Gitt AK, Zahn R.

Herz. 2016 Aug;41(5):413-20. doi: 10.1007/s00059-016-4457-x. Epub 2016 Jul 13. Review. German.

PMID:
27412663
13.

LDL cholesterol goals in high-risk patients: how low do we go and how do we get there?

Besseling J, van Capelleveen J, Kastelein JJ, Hovingh GK.

Drugs. 2013 Mar;73(4):293-301. doi: 10.1007/s40265-013-0028-0. Review.

PMID:
23494186
14.

Ezetimibe.

Harris M, Davis W, Brown WV.

Drugs Today (Barc). 2003 Apr;39(4):229-47. Review.

PMID:
12743640
15.

Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management.

Zárate A, Manuel-Apolinar L, Saucedo R, Hernández-Valencia M, Basurto L.

Arch Med Res. 2016 Oct;47(7):491-495. doi: 10.1016/j.arcmed.2016.11.009. Review.

PMID:
28262189
16.

[New possibilities of correction of hypercholesterolemia in patients with diabetes mellitus].

Pan'kiv VI.

Lik Sprava. 2014 May-Jun;(5-6):56-67. Review. Russian.

PMID:
25906648
17.

[ANMCO Position paper: Clinical management of hypercholesterolemia in patients with acute coronary syndrome].

Colivicchi F, Gulizia MM, Arca M, Abrignani MG, Perna GP, Mureddu GF, Nardi F, Riccio C; ANMCO.

G Ital Cardiol (Rome). 2016 Jun;17(6):456-61. doi: 10.1714/2262.24350. Italian.

PMID:
27311088
18.

Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase.

Bilen O, Ballantyne CM.

Curr Atheroscler Rep. 2016 Oct;18(10):61. Review.

19.

[Selective cholesterol absorption inhibition as a new prospect in treatment of hypercholesterolemia].

Lima J, Fonollosa V, Chacón P.

Med Clin (Barc). 2005 Jun 4;125(1):16-23. Review. Spanish.

PMID:
15960941
20.

How will new medications affect the lipoprotein apheresis situation in Germany?

Parhofer KG.

Atheroscler Suppl. 2013 Jan;14(1):71-2. doi: 10.1016/j.atherosclerosissup.2012.10.022. Review.

PMID:
23357144

Supplemental Content

Support Center